Last reviewed · How we verify

NCT06888401

Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal

Completed Last updated 21 March 2025
What this trial tests

trial testing ERCP in Cholangiocarcinoma in 597 participants. Completed in 1 March 2023.

Timeline
1 January 2017
Primary endpoint
1 January 2023
1 March 2023

Quick facts

Lead sponsorKathmandu University School of Medical Sciences
StatusCompleted
Study typeOBSERVATIONAL
Enrollment597
Start date1 January 2017
Primary completion1 January 2023
Estimated completion1 March 2023
Sites1 location across Nepal

Drugs / interventions tested

Conditions studied

Sponsor

Kathmandu University School of Medical Sciences

Who can join

18 and older, any sex, with Cholangiocarcinoma or Bile Duct Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background Pancreaticobiliary malignancy (PBM) is a group of cancers affecting pancreas and bile duct. The diagnosis is often late and with fatal outcomes. Here, investigators study the clinicodemographic profile of the patients with suspected PBM undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) at a tertiary care center in Nepal. Material and Methods Retrospectively, a descriptive cross-sectional study was conducted at the endoscopy unit of the Internal medicine department of Dhulikhel Hospital-Kathmandu University Hospital (DH-KUH) from Jan 2017 to Jan 2023. Patients over 18 years of age with suspected PBM with complete medical records who underwent ERCP were included in our study. The descriptive and correlation statistics were done.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ERCP

Trials testing the same drug.

Other recruiting trials for Cholangiocarcinoma

Currently open trials in the same condition.

Other Kathmandu University School of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06888401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing